epi pen generic-most likely coming out in 2017

BunsenBurner
Mon, 29 Aug 2016 18:50:49 +0000

^^Proves my point precisely. The public is outraged - but only by what is visible, i.e., Mylan. It is easy to blame the greedy manufacturers because we all know where the product originates and where it ends. But where and how it travels between these two points is a black box to the consumer. The invisible middlemen that take a huge chunk of what the patient pays… stay invisible and continue their conduct.

I am not trying to defend the Mylan’s pricing, just pointing out that there is more to the story than the headlines make you think there is.